Anti-GAD2 monoclonal antibody

Pre-made anti-GAD2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GAD2/GAD2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T22128-Ab-1/ GM-Tg-hg-T22128-Ab-2Anti-Human GAD2 monoclonal antibodyHuman
GM-Tg-rg-T22128-Ab-1/ GM-Tg-rg-T22128-Ab-2Anti-Rat GAD2 monoclonal antibodyRat
GM-Tg-mg-T22128-Ab-1/ GM-Tg-mg-T22128-Ab-2Anti-Mouse GAD2 monoclonal antibodyMouse
GM-Tg-cynog-T22128-Ab-1/ GM-Tg-cynog-T22128-Ab-2Anti-Cynomolgus/ Rhesus macaque GAD2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T22128-Ab-1/ GM-Tg-felg-T22128-Ab-2Anti-Feline GAD2 monoclonal antibodyFeline
GM-Tg-cang-T22128-Ab-1/ GM-Tg-cang-T22128-Ab-2Anti-Canine GAD2 monoclonal antibodyCanine
GM-Tg-bovg-T22128-Ab-1/ GM-Tg-bovg-T22128-Ab-2Anti-Bovine GAD2 monoclonal antibodyBovine
GM-Tg-equg-T22128-Ab-1/ GM-Tg-equg-T22128-Ab-2Anti-Equine GAD2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T22128-Ab-1/ GM-Tg-hg-T22128-Ab-2; GM-Tg-rg-T22128-Ab-1/ GM-Tg-rg-T22128-Ab-2;
GM-Tg-mg-T22128-Ab-1/ GM-Tg-mg-T22128-Ab-2; GM-Tg-cynog-T22128-Ab-1/ GM-Tg-cynog-T22128-Ab-2;
GM-Tg-felg-T22128-Ab-1/ GM-Tg-felg-T22128-Ab-2; GM-Tg-cang-T22128-Ab-1/ GM-Tg-cang-T22128-Ab-2;
GM-Tg-bovg-T22128-Ab-1/ GM-Tg-bovg-T22128-Ab-2; GM-Tg-equg-T22128-Ab-1/ GM-Tg-equg-T22128-Ab-2
Products NameAnti-GAD2 monoclonal antibody
Formatmab
Target NameGAD2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GAD2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T22128-Ag-1Recombinant multi-species DCE2/ GAD2/ GAD65 protein
    ORF Viral VectorpGMLP003929human GAD2 Lentivirus plasmid
    ORF Viral VectorvGMLP003929human GAD2 Lentivirus particle
    ORF Viral VectorpGMLPm004442mouse Gad2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004442mouse Gad2 Lentivirus particle


    Target information

    Target IDGM-T22128
    Target NameGAD2
    Gene ID2572,14417,24380,613029,487107,101082244,512459,100055419
    Gene Symbol and Synonyms6330404F12Rik,GAD(65),Gad-2,GAD2,GAD65
    Uniprot AccessionQ05329,Q05683,Q4PRC2
    Uniprot Entry NameDCE2_HUMAN,DCE2_RAT,DCE2_CANLF
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000136750
    Target ClassificationN/A

    The target: GAD2, gene name: GAD2, also named as GAD65. This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.